CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,406,000 | -30.9% | 872,415 | -14.9% | 4.22% | -12.0% |
| Q4 2020 | $29,514,000 | -49.1% | 1,024,800 | -64.2% | 4.79% | -8.1% |
| Q3 2020 | $57,983,000 | -44.6% | 2,861,924 | -17.8% | 5.22% | -37.6% |
| Q2 2020 | $104,574,000 | +68.3% | 3,480,000 | +76.0% | 8.36% | +28.7% |
| Q1 2020 | $62,153,000 | +16.2% | 1,977,502 | +74.2% | 6.49% | +39.5% |
| Q4 2019 | $53,476,000 | – | 1,135,122 | – | 4.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |